PubRank

Athanasios G Tzioufas

Author PubWeight™ 48.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of primary Sjögren syndrome: a systematic review. JAMA 2010 2.37
2 Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Ann Rheum Dis 2007 1.83
3 Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 2007 1.71
4 Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus. J Rheumatol 2008 1.47
5 Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun 2011 1.46
6 Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol 2010 1.43
7 Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol 2012 1.41
8 Longterm followup after tapering mycophenolate mofetil during maintenance treatment for proliferative lupus nephritis. J Rheumatol 2011 1.39
9 Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006 1.21
10 Topical and systemic medications for the treatment of primary Sjögren's syndrome. Nat Rev Rheumatol 2012 1.19
11 Sjögren's syndrome--study of autoantigens and autoantibodies. Clin Rev Allergy Immunol 2007 1.16
12 Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis 2012 1.14
13 Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc Natl Acad Sci U S A 2012 1.10
14 Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome. Medicine (Baltimore) 2012 1.09
15 Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response. J Autoimmun 2003 1.09
16 Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun 2006 1.07
17 Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens. Clin Immunol 2008 1.06
18 Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study. Arthritis Res Ther 2011 1.04
19 Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response. Crit Rev Clin Lab Sci 2006 1.00
20 Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol 2002 0.98
21 Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants. Mol Med 2002 0.98
22 Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev 2005 0.97
23 Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun 2009 0.94
24 The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin Chim Acta 2004 0.92
25 Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome. Arthritis Rheum 2013 0.91
26 Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. J Autoimmun 2012 0.91
27 Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun 2011 0.91
28 Autoimmune response and target autoantigens in Sjogren's syndrome. Eur J Clin Invest 2010 0.90
29 The role of chaperone proteins in autoimmunity. Ann N Y Acad Sci 2006 0.88
30 Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One 2013 0.87
31 RNA recognition motif (RRM) of La/SSB: the bridge for interparticle spreading of autoimmune response to U1-RNP. Mol Med 2009 0.87
32 Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia. J Infect Dis 2011 0.86
33 The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot study. J Neurol Sci 2013 0.86
34 B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response. J Autoimmun 2010 0.85
35 Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry 2010 0.84
36 Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthritis Rheum 2006 0.84
37 Minor salivary gland inflammatory lesions in Sjögren syndrome: do they evolve? J Rheumatol 2013 0.84
38 The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis. Ann Rheum Dis 2011 0.82
39 Lymphoma development in a patient receiving anti-TNF therapy. Haematologica 2003 0.80
40 Linear epitopes of two different autoantigens-La/SSB and myelin basic protein--with a high degree of molecular similarity, cause different humoral immune responses. J Autoimmun 2003 0.80
41 Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. Arthritis Rheum 2011 0.80
42 Zinc ion dependent B-cell epitope, associated with primary Sjogren's syndrome, resides within the putative zinc finger domain of Ro60kD autoantigen: physical and immunologic properties. J Med Chem 2004 0.80
43 Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study. Arthritis Res Ther 2010 0.78
44 Current Aspects of Pathogenesis in Sjögren's Syndrome. Ther Adv Musculoskelet Dis 2010 0.78
45 Acquired angioedema: a new target for rituximab? Haematologica 2004 0.77
46 Indications for bone marrow examination in autoimmune disorders with concurrent haematologic alterations. Clin Exp Rheumatol 2012 0.76
47 Clinical and laboratory predictors of distinct histopathogical features of lupus nephritis. Medicine (Baltimore) 2015 0.75
48 Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4. Autoimmunity 2015 0.75
49 Demographics, clinical characteristics and predictive factors for total knee or hip replacement in patients with rheumatoid arthritis in Greece. Clin Exp Rheumatol 2012 0.75
50 Periodic fevers in adult Greeks: clinical and molecular presentation. Clin Exp Rheumatol 2014 0.75
51 Functional expression of the alpha 2-macroglobulin receptor CD91 in salivary gland epithelial cells. J Autoimmun 2009 0.75
52 B-cell chronic lymphocytic leukaemia presenting as lower motor neuron disease and SS. Rheumatology (Oxford) 2012 0.75
53 Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice. Arthritis Rheum 2007 0.75
54 [Sjögren syndrome. New therapeutic approaches]. Med Clin (Barc) 2005 0.75